Intelligent Investors Den!
Sign up Now and Gain Access to Exciting Opportunities from Investor and Resource Space!
By submitting your details and clicking on the SIGN UP button you agree to Kalkine’s Free Trial-Terms of Use and consent to receive marketing offers including to be contacted by email or phone, as set out in our Privacy Policy Any calls will be made by Kalkine Pty Ltd or Kalkine Solutions Private Limited on our behalf. You also agree that Kalkine/KSPL can give you its Financial Services Guide by electronic means (including by website link or email). Before accessing our services, please read the Financial Services Guide available here.
By creating account you will get access to hot stocks & personalised emails
Any calls will be made by Kalkine Pty Ltd or Kalkine Solutions Private Limited on our behalf.
Last update at 2024-12-12T00:54:00Z
ASX's Top 3 Estimated Undervalued Stocks For September 2024
With 76% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional owners
Atlas Arteria Ltd's Dividend Analysis
Atlas Arteria Full Year 2023 Earnings: EPS: AU$0.22 (vs AU$0.25 in FY 2022)
With 78% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional owners
With 80% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional owners
Atlas Arteria Full Year 2022 Earnings: Misses Expectations
With 81% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional owners
Multiple insiders bought Atlas Arteria Limited (ASX:ALX) stock earlier this year, a positive sign for shareholders
Share Sales Tied to M&A to Keep Aussie Bankers Busy, UBS Says